By Jefferey Jaxen
Remember Swine Flu? It was a big deal for a little while, but now it’s something nobody in corporate media wants to talk much about.
On October 2009, Anthony Fauci, US National Institutes of Health infectious diseases chief, appears on YouTube. He reassures Americans about the safety of the “swine flu” vaccine, saying “there doesn’t appear to be any safety red flags or safety issues…The track record for serious adverse events is very good. It’s very, very, very rare that you ever see anything that’s associated with the vaccine that’s a serious event.”
The World Health Organization gave the swine flu its most alarmed rating—a global pandemic—despite a relatively uneventful number of actual swine flu deaths. According to the U.S. Centers for Disease Control and Prevention (CDC) there were 61,000 deaths in 2018 and 38,000 the year before. There were 18,500 lab-confirmed deaths during the swine flu ‘pandemic’ year. Not great, but not a pandemic.
Yet in late July of 2009, the CDC abruptly advised states to stop testing for H1N1 flu. Stop counting individual cases, too, the CDC instructed.
CBS News reported that the decision to stop counting H1N1 flu cases was made so hastily that states weren’t given the opportunity to provide input.
Investigative reporter Sharyl Attkisson dug into state-by-state numbers of positively-confirmed swine flu cases, but she and her CBS team were stonewalled by the CDC for months. Finally, rather than wait for the CDC, reporters took the initiative to contact each state individually and found: “Of the presumed likely swine flu cases, only a fraction of them were actually swine flu.”
Health agencies had an overhyped event and a brand new stockpile of experimental vaccines to use. They didn’t waste time distributing them, despite the public and some media starting to see through the faux “pandemic.”
In December 2009, demonstrators in Scotland took to the streets to challenge the government’s swine flu vaccine campaign, arguing it was out of step with the mild flu virus. Protestors had safety concerns. The vaccine had not gone through proper testing, and the Scottish citizenry decided it was best to look out for themselves and their own families.
GlaxoSmithKline’s (GSK) swine flu vaccine, Pandemrix, immediately began seeing reports of “adverse effects.” Internal GSK documents obtained via court proceedings were analyzed by The BMJ who wrote:
“For a range of concerning adverse events, reports were coming in for Pandemrix at a consistently higher rate than for the other two GSK pandemic vaccines–four times the rate of facial palsy, eight times the rate of serious adverse events, nine times the rate of convulsions.”
It was a cover up. Neither GSK, nor the health authorities made the information transparent for the public. In many of the GSK reports, the company briefly mentions having conducted “safety reviews”—for example, with respect to anaphylaxis, facial palsy, and Guillain-Barré syndrome. But when The BMJ asked GSK for a copy of those reviews, the pharmaceutical company refused to provide them.
The rough waters seen in 2009 became a tidal wave in 2014, when the UK government was hit with massive injury penalty payoffs from the wave of injuries that followed the swine flu vaccine push.
International Business Times U.K. Edition headlined: Brain-Damaged UK Victims of Swine Flu Vaccine to Get £60 Million Compensation. Each of the victims is “expected to receive £1 million each.”
Peter Todd, a lawyer who represented many of the claimants, told the Sunday Times (U.K.): “There has never been a case like this before. The victims of this vaccine have an incurable and lifelong condition and will require extensive medication.”
The race was on. Health authorities circled the wagons. They hid evidence of vaccine damage. They defended against the onslaught of suits headed their way.
In 2015, a 12-year-old boy in the UK named John was awarded £120,000 by a court that ruled he had been left severely disabled by narcolepsy caused by the vaccine. He was seven when he had the jab and developed symptoms within months.
In an effort to stem the growing number of people—mostly children—seeking compensation for narcolepsy caused by the untested swine flu shot, the UK government fought John’s case. The Department for Work and Pensions (DPW) argued John’s disability was not serious enough to warrant compensation and said the court was wrong to take into account how the illness would affect him in the future. John won the case in 2017.
The judgment meant the DWP now had to take into account the impact a disability has on a person’s entire life, and not just the impact it has on the individual at the time their claim is made.
In another case of duplicitous government actions, in 2015, Ireland’s Health Service Executive (HSE) promised to voluntarily disclose internal documentation related to their handling of the swine flu vaccine and its program.
But two years later, in 2017, both HSE and the State Claims Agency were in the nation’s High Court, attempting to obstruct plaintiffs from getting exactly those documents under discovery.
At the onset of the ‘pandemic’ in 2009, the Irish Medicines Board warned Chief Medical Officer of the HSE, Tony Holohan, that none of the swine flu vaccines had been fully tested and ‘no safety data’ was available. Clinicians would be prescribing it without knowing what possible side-effects it might have.
Ignoring the facts, the HSE released a leaflet a month later, advising pregnant women that they should get the vaccine stating “The vaccines are fully licensed and clinically tested.”
In 2017 Irish TD (Parliament member) Clare Daly challenged Ireland’s Taoiseach (Prime Minister) during a televised hearing. Her words were searing and left Ireland’s failed HSE with a public black eye.
In 2018, multiple Irish governmental health bodies were involved in ongoing litigation. The BMJ requested an update on the investigation from the Irish Department of Health, but did not receive a direct answer.
Now, just recently, an Irish High Court decided damages should be paid to a student who developed the sleep disorder narcolepsy after receiving the swine flu. It was seen as a test case for up to 100 more cases. The court had been asked to determine if any or all of the defendants, including the vaccine maker and the State, were liable for damages.
The defendants in the case were GlaxoSmithKline Biologicals, the Health Service Executive, the Minister for Health and the Health Products Regulatory Authority, formerly the Irish Medicines Board.
All claims made in the case were denied and the settlement was made without admission of liability. No orders were made against the HPRA or GSK. Essentially, the Irish taxpayers get to float the bill for damage caused by the failed swine flu vaccine campaign. The court also ordered the settled amount to be sealed from the public.
What does the public learn from such a fiasco? The concoction of a public health crisis to spur vaccine sales?
No wonder vaccine products, which have not been properly safety tested, are being increasingly rejected. Shunned not because of misinformation, but because of the government’s self-inflicted loss of faith, coupled with its deep collusion with pharmaceutical companies where profits over people is their modus operandi.